These specialised professionals work alongside sites to uncover recruitment challenges early, using clinical expertise and ...

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik for adults with type 2 diabetes, setting up a market tussle with Novo over its recently launched Awiqli. Onswik (insulin ...

Kyverna Therapeutics has reported new data with its cell therapy for the rare autoimmune disease stiff person syndrome (SPS), ...

That's where The PM Society comes in. As the professional organisation for people working in pharmaceutical marketing and healthcare communications, The PM Society brings together peers from across ...

Eli Lilly has continued a busy period of deal-making with a wide-ranging partnership with China's InnoCare Pharma that includes upfront and near-term payments of $100 million. There's another $3.25 ...

T-cell therapy has been transformational in treating liquid tumours, historically, translation to application in solid tumours has faced biological barriers. Nonetheless, in June 2026, China approved ...

The infiltration took place in June, but OpenAI has indicated it only became aware of the incident in August and notified the ...